Kowal Investment Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-23
Closed -$2K 172
2021
Q3
$2K Buy
+23
New +$1.93K ﹤0.01% 776

Other funds holding ARKG

Kowal Investment Group's ARKG Position: Q4 2021 in Review

Kowal Investment Group sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 23 shares — an estimated $2K sold.

Kowal Investment Group first reported a position in ARKG in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

  • Kowal Investment Group reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
  • Kowal Investment Group sold 23 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $2K.
  • Kowal Investment Group first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 1 quarter.
  • Kowal Investment Group's ARK Genomic Revolution ETF position peaked at $2K in Q3 2021.
  • 460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.